Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DR. DONALD AS
AS
Active
Org 911849771
Nordengveien 51, 0755
Oslo
Allmenn legetjeneste
· NACE 86211
Est. 2013
0 employees
Watchlist
Share
Norway
/
Companies
/
Allmenn legetjeneste
/
DR. DONALD AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
2M
3M
3M
3M
2019
3M
2020
2M
2021
2M
2022
1M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2019
1M
2020
1M
2021
1M
2022
1M
2023
Income statement
NOK thousands
Item
2019
2020
2021
2022
2023
Revenue
3 131
2 569
2 278
1 975
1 141
Staff expenses
−91
−90
−92
−105
−25
EBITDA
1 413
1 208
1 072
881
626
Depreciation & amort.
−173
−173
−173
−173
−43
EBIT
1 240
1 035
899
708
582
Net financials
1
0
0
−0
0
Profit before tax
1 240
1 035
899
708
582
Tax
273
228
198
156
128
Net profit
968
807
701
553
454
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
2023
Total assets
1 482
1 176
1 266
1 381
678
Equity
80
87
88
91
42
Long-term debt
9
0
0
0
0
Short-term debt
1 394
1 089
1 178
1 290
636
Total debt
1 402
1 089
1 178
1 290
636
Financial ratios
5-year trend
EBITDA margin
54.8%
This company
15.8%
Market median
+247% vs market
2019
2023
Equity ratio
6.2%
This company
38.2%
Market median
-84% vs market
2019
2023
Return on equity
1073.1%
This company
18.4%
Market median
+5732% vs market
2019
2023
Net profit margin
39.8%
This company
8.1%
Market median
+391% vs market
2019
2023
Asset turnover
1.68×
This company
1.12×
Market median
+50% vs market
2019
2023
Debt / equity
15.03×
This company
0.62×
Market median
-2324% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
More on DR. DONALD AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network